Clinical Reference Laboratory Testing Services

This document, Amendment/Modification Number 0001 to Solicitation Number HT001526RE001, issued by the DHA Enterprise Med Support EMS-CD on May 22, 2026, officially amends the original solicitation dated May 13, 2026. The primary purpose of this amendment is to incorporate revised Addendums to FAR 52.212-1 and FAR 52.212-2, with changes highlighted in yellow, and to include Exhibit B - Q&A Matrix - Government Responses. This amendment also details the addition of new attachments, specifically updated versions of Attachment 2 (Addendum to FAR 52.212-1) and Attachment 3 (Addendum to FAR 52.212-2), and Exhibit B (CRLTS - HT001526RE001 - Q&A Matrix - Govt Responses). Concurrently, previous versions of these attachments have been deleted. The document outlines the procedures for offerors to acknowledge receipt of the amendment and notes that all other terms and conditions of the original solicitation remain unchanged.

The Defense Health Agency (DHA) issued an Addendum to FAR 52.212-1 for a single Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Reference Laboratory Services. This acquisition uses the new FAR Overhaul, with proposals due as specified on SF-1449. The addendum customizes instructions for offerors, including a 180-day price hold and debriefings for unsuccessful offerors. Proposals must adhere to strict formatting, submission via email (20MB max), and content guidelines across five volumes: Business, Technical, Performance Risk, Small Business Subcontracting, and Price. The government plans to award based on best value, evaluating initial proposals in descending order of importance: Technical, Performance Risk, Small Business Subcontracting, and Price. Non-price factors are significantly more important than price. Technical proposals require a detailed approach, adherence to CMMC compliance, and specific supporting documentation for sub-factors like cybersecurity, transition, LIS deployment, technical requirements, quality control, and supply chain management. Performance risk evaluates past and present performance, while small business subcontracting participation is a key factor with minimum percentage goals. Price proposals require firm-fixed prices for ten years, with no offeror-added escalation, as the government will calculate a Total Evaluated Price (TEP) including a 5% maximum escalation ceiling for evaluation purposes.

The Defense Health Agency plans to award a single Indefinite Delivery/Indefinite Quantity contract for Reference Laboratory Services, utilizing the new Federal Acquisition Regulation (FAR) Overhaul. The contract includes a five-year base ordering period and a five-year option. Proposals will be evaluated based on a best-value tradeoff process, considering technical, performance risk, small business subcontracting participation, and price factors, listed in descending order of importance. Non-price factors are significantly more important than price. To be considered for award, proposals must meet specific minimum requirements, including an "Acceptable" rating for the Technical Factor and "Satisfactory Confidence" or higher for Performance Risk. Proposals must also have an "Acceptable" Small Business Subcontracting Participation and a fair, reasonable, and balanced price. The government intends to award without negotiations but may conduct them if necessary. The evaluation process emphasizes clear, comprehensive proposals that demonstrate compliance with all requirements.

This document addresses questions and concerns regarding RFP HT001526RE001 for Clinical Reference Laboratory Testing Services. A key point of contention is the mandatory small business subcontracting participation factor, which the government declines to remove, citing DFARS regulations. However, the evaluation criteria for Factor 3 will be tailored to allow for 'Good Faith Effort' explanations with verifiable documentation if quantitative goals are not met, acknowledging market realities and stringent regulatory requirements. The government clarifies that subcontracting goals are calculated against Total Contract Value, and meaningful small business participation, including mission-relevant work, is encouraged. The RFP's proposal due date remains May 18, 2026, and OCONUS test volume estimates are provided.